420Patients.com is accepting qualified medical marijuana patients and caregivers to join our network. We value every registered member and we hope to serve you in Arizona. This article brought to you by 420 community friends mmjbusinessdaily.com
An Australian developer of marijuana-based medicines that debuted on the Australian Securities Exchange Thursday saw its stock soar 38% above its offering price before settling in to close 30% above its listing price.
The Sydney Morning Herald valued Creso Pharma at about $11.5 million Australian dollars (about $9.7 million).
The company (CPH AX) listed on the ASX with an issue price of AU$0.20 cents per share, but the offering was heavily oversubscribed, according to the Sydney Morning Herald, pushing up Cresco’s opening price for the day to AU$0.25 cents. The West Perth-based company hit a high